Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results.

Slides:



Advertisements
Similar presentations
Practical Blood Bank Lab Adsorption.
Advertisements

Dr. Mohammed H Saiemaldahr BLOOD BANK MED TECH
Antibody Identification
“It’s Just a Panel … It’s not Rocket Science”
CLS 3311 Advanced Clinical Immunohematology
Antibody Identification
September 2007 Dr Debra Lane
Dr. MH Saiemaldahr Blood Bank
Practical Blood Bank Antibody Screening Lab 6.
Identifying Antibodies
ANTIGLOBULIN TEST and ANTIBODY DETECTION
Rh/D y grupos débiles de D, de notas de internet Notas amables, sencillas, claras de apoyo en el estudio del tema.
Unit #5F – Clinical Laboratory Testing – Basic Immunohematology Cecile Sanders, M.Ed., MLS(ASCP)
Blood Type Ch. 14 and Section 37.2.
ABO & Rh Discrepancies.
Antibody Identification
Antibody Titration.
2 pt 3 pt 4 pt 5pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2pt 3 pt 4pt 5 pt 1pt 2pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4pt 5 pt 1pt DEFINITIONS NAME THAT ANTIGEN DISEASE.
ABO & Rh Discrepancies.
2 pt 3 pt 4 pt 5pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2pt 3 pt 4pt 5 pt 1pt 2pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4pt 5 pt 1pt REACTIVITY NAME THAT ANTIBODY COLDSGENETICS.
Detecting Antibodies The Antibody Screen CLS 422
Drmsaiem. OTHER BLOOD GROUPS DR MOHAMMED H SAIEM ALDAHR Faculty of Applied Medical Sciences MED TECH DEP. 3 RD YEAR MT.
ABO Blood Grouping Introduction Terry Kotrla, MS, MT(ASCP)BB.
Antibody Detection Mohammed Jaber.
Joan Cid, Núria Nogués, Rosa Montero, Marta Hurtado, Albert Briega and Rafael Parra. Blood and Tissue Bank. Barcelona, Spain. Comparison of three microtube.
BB. MLT Lec.6.Mr. Waggas.
Detection and Identification of alloantibodies to Red Cell Antigens
Unit 9 Other Blood Group Systems Part 2
Other Blood Group Systems
ABO/D Blood Groups Understanding Critical For Safe Transfusions.
Antibody Screening / Detection & Antibody Identification
Practical Blood Bank Lab 4 Weak D testing (Du).
Immunologic Methods Part One Antigen-Antibody Reactions CLS 420 Clinical Immunology & Molecular Diagnostics.
Antibody Screening and Identification
Alloantibodies causing Hemolytic Disease of the Newborn and Fetus. Nancy Benitez, BS, MHS (ASCP)SBB CM Reference Laboratory Director June 6, 2013.
INCOMPLETE CROSSMATCH
The need is constant. The gratification is instant. Give blood. TM Transfusion Medicine Case Studies Patient GJ March 2010 John N. McLennan, MT(ASCP) Midwest.
Unit 8 Pretransfusion Testing Part 2
Welcome Back to Immunohematology Other Antigen Systems Part II – Kell, Duffy, Kidd, MNSs.
Antiglobulin Test.
1 Summary September 25-26, 2006 FDA Workshop Molecular Methods in Immunohematology 89 th Meeting of BPAC April 27, 2007 Sheryl A. Kochman Chief, Devices.
Practical Blood Bank ABO Discrepancies 2.
ABO System. How is blood classified? Blood is classified according to the nature of the chemical substances known as antigens or markers, which are microscopic.
Faculty of Allied Medical Science Blood Banking (MLBB 201)
Antibody Detection & Identification Review
Identification of antibody mixes that give a complete covering of diagnostic panels reactions. Identification of weak, only partially reacting antibodies.
Practical Blood Bank Lab 4 Weak D testing (Du).
Blood Groups and Transfusions. Blood Loss Body is only able to compensate for minor losses – 15-30% cause weakness – >30% body goes into shock Can be.
Serological Testing In Blood Transfusion Services
Nada Mohamed Ahmed , MSc, MT (ASCP)i
Terry Kotrla, MS, MT(ASCP)BB Unit 8 Pretransfusion Testing Part 1.
Other Blood Group Systems
Chapter 9: Introduction to the t statistic. The t Statistic The t statistic allows researchers to use sample data to test hypotheses about an unknown.
Part III. Essentials of Pretransfusion Testing.
Unit #6F – Clinical Laboratory Testing – Basic Immunohematology Cecile Sanders, M.Ed., MT(ASCP), CLS (NCA)
ABO Typing Discrepancies
Practical Blood Bank Lab 3 Rh Grouping.
Poster Title Weak D Types in the Egyptian Population Eiman Hussein, MD 1 and Jun Teruya, MD, DSc 2 Clinical Pathology, Division of Transfusion Medicine.
Welcome Back to Immunohematology Other Antigen Systems Part III – Lewis, P, Lutheran, Xg, I.
Immunohematology Transfusion Medicine Blood Bank
Minor Blood Group Systems
Unit 9 Other Blood Group Systems Part 1
Another Type of Incomplete Dominance - Codominance.
Reagents and Methods for Testing in the Blood Bank
History of the ABO system Karl Landsteiner is the father of what we know as Blood banking. He discovered the ABO blood groups in 1900 by observing the.
Detection and Identification of alloantibodies to Red Cell Antigens
RED BLOOD CELLS.
Blood Type 3 Alleles for blood type: ____, ____, ______
Blood Type and Multiple Alleles
Blood Type and Multiple Alleles
Presentation transcript:

Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results

Performing selected tests Determining the strength & pattern of agglutination Interpreting results Selecting suitable blood for the patient Antibody Identification Involves YOU as the Expert!

Define Antibody Exclusion List advantages of crossing out in Ab Identification Describe limitations of the cross-out process Identify helpful patient and reagent information Discuss AABB Standards on assigning Ab specificity Recognize homozygous vs. heterozygous expression Apply recommended rules for crossing out Objectives

Systematic process by which panel results are interpreted to eliminate antibody specificities on the basis of non- reactivity of patient plasma with red cell samples that express the antigen. -AABB Technical Manual 16 th edition “Antibody Exclusion” – Immunohematology definition

Commonly known as… “Antibody Exclusion” – Immunohematology definition Crossing-Out

1. Allows accurate ID of antibodies 2. Eliminates additional antibody specificities 3. Provides higher predictive value 4. Supports initial hypothesis 5. Determines additional testing 6. Decreases delay in patient care Advantages of Crossing-Out

A first approach May not lead directly to an answer A provisional step Converging evidence ??? Crossing Out

Patient’s phenotype Ethnicity of the patient Ethnicity of panel cell donor Age of the panel cell Helpful Information

Cross-Out protocol varies by institution Recommended rules for Crossing-Out

To increase the probability of correct identification a p-value of <0.05 is observed which gives a 95% confidence interval. What about Ruling-In?

Standards for Immunohematology Reference Laboratories-6 th Edition “Assign specificity after demonstrating reactivity with at least two antigen-positive reagent red cell samples and non-reactivity with at least two antigen-negative reagent red cell samples.” AABB IRL Standards

Recommended rules for Crossing-Out

It is best to rule out an antibody specificity on a cell with a double-dose expression Homozygous alleles- Jk a /Jk a (Double-Dose) express Jk(a+b-) Heterozygous alleles - Jk a /Jk b (Single-Dose) express Jk(a+b+) Rule #1

It is best to rule out an antibody specificity on a cell with a double-dose expression Exceptions… K1 and P 1 C or E with Anti-D Rule #1

It is better to rule out specificities with two unique cells rather than one By chance, one may not react as well as expected due to: Variant antigen structure Lack of antigen recognition by antibody Weakened antigen expression Antigen degradation Tech error Rule #2

“ Reverse of Rule-out ”- for the antibody that shows extreme variability or reacts in more than one phase of testing Anti-P 1 Anti-Le a Anti-Le b Rule #3

Antibody Exclusion alone does not define which antibodies are or are not present Additional Techniques : Selected Cells Chemical Treatment Proteolytic Enzymes - Papain, Ficin, Bromelin Sulfhydryl Reagents - DTT & AET Neutralization P 1 & Lewis Rule #4

If antibodies to common blood group antigens cannot be ruled out, it may be necessary to consult a Blood Bank Reference Laboratory or provide antigen negative units. When All Else Fails

On the following example panels, try crossing out each blood group antigen with at least one homozygous representation. Example Panels

CELL RHKellDuffyKiddLewisPMNS CELLGEL IAT IAT DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs s+s AC 0 (Panel A) Example #1

CELL RHKellDuffyKiddLewisPMNS CELLGEL IAT IAT DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs S+S AC 0 (Panel A) Example #2

CELL RHKellDuffyKiddLewisPMNS CELLGEL IAT IAT DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs S+S S+S S+S AC 0 (Panel B) Example #2

CELL RHKellDuffyKiddLewisPMNS CELLGEL IAT IAT DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs s+s AC 0 (Panel A) Example #3

CELL RHKellDuffyKiddLewisPMNS CELLLISS 37 o LISSIAT DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs AC 00 Example #4

CELL RHKellDuffyKiddLewisPMNS CELLLISSIAT DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs w w w S+S AC 0 Example #5

CELL RHKellDuffyKiddLewisPMNS CELLRT15’ P 1 Neut.RT15’ DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs S+S AC (RT & P 1 Neut.) Example #5

CELL RHKellDuffyKiddLewisPMNS CELLLISS 37 o LISSIAT DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs AC 00 Example #6

CELL RHKellDuffyKiddLewisPMNS CELLLISSIAT DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs AC 0 Example #7

CELL RHKellDuffyKiddLewisPMNS LISSIATENZ IAT IATDTTIAT DCEceKk Fy a Fy b Jk a Jk b Le a Le b P1P1P1P1MNSs AC0 (Chemicals) Example #7